Synaptic dysfunction in Alzheimer's disease: Mechanisms and therapeutic strategies | |
Amy K.Y. Fu; Yu Chen; Nancy Y. Ip | |
刊名 | PHARMACOLOGY & THERAPEUTICS
![]() |
2018 | |
文献子类 | 期刊论文 |
英文摘要 | Alzheimer's disease (AD), the most prevalent neurodegenerative disease in the elderly population, is characterized by progressive cognitive decline and pathological hallmarks of amyloid plaques and neurofibrillary tangles. However, its pathophysiological mechanisms are poorly understood, and diagnostic tools and interventions are limited. Here, we review recent research on the amyloid hypothesis and beta-amyloid–induced dysfunction of neuronal synapses through distinct cell surface receptors. We also review how tau protein leads to synaptotoxicity through pathological modification, localization, and propagation. Finally, we discuss experimental therapeutics for AD and propose potential applications of disease-modifying strategies targeting synaptic failure for improved treatment of AD. |
URL标识 | 查看原文 |
语种 | 英语 |
内容类型 | 期刊论文 |
源URL | [http://ir.siat.ac.cn:8080/handle/172644/13880] ![]() |
专题 | 深圳先进技术研究院_脑所 |
推荐引用方式 GB/T 7714 | Amy K.Y. Fu,Yu Chen,Nancy Y. Ip. Synaptic dysfunction in Alzheimer's disease: Mechanisms and therapeutic strategies[J]. PHARMACOLOGY & THERAPEUTICS,2018. |
APA | Amy K.Y. Fu,Yu Chen,&Nancy Y. Ip.(2018).Synaptic dysfunction in Alzheimer's disease: Mechanisms and therapeutic strategies.PHARMACOLOGY & THERAPEUTICS. |
MLA | Amy K.Y. Fu,et al."Synaptic dysfunction in Alzheimer's disease: Mechanisms and therapeutic strategies".PHARMACOLOGY & THERAPEUTICS (2018). |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论